• About Us  
    • Our Mission
    • Company Profile
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
  • ProTcell platform
  • Pipeline
  • News 
    • Press releases
    • Smart Stories
  • Partnering
  • Contact

Press Releases

All
Smart Stories
All
Press Releases
All
Factsheets

Smart Immune appoints world-class Clinical Advisory Board

November 21, 2022

Smart Immune and Greater Paris University Hospitals (AP-HP) begin groundbreaking Phase I/II trial with ProTcellTM, a thymus-empowered T-cell therapy platform, in adults with blood cancers

October 13, 2022

Smart Immune Bolsters Management Team with Medical and Technical Appointments

September 13, 2022

Smart Immune appoints world-leading experts to its Scientific Advisory Board 

July 28, 2022

Marcel R. M. van den Brink, MD, PhD Appointed Chairman of Smart Immune’s Scientific Advisory Board

July 6, 2022

Smart Immune Announces Oral Presentation of Cell Fate Plasticity Data of its T-cell Progenitor-Based Therapy Platform (ProTcell™) at ASGCT 2022

May 20, 2022
←
Previous
Next
→
© 2021 Smart Immune SAS
Legal NoticeFAQ
